GT Biopharma GTBP
NASDAQ GTBP
$3.72 -0.12 (-3.12%)
At close: Nov 13, 2026 · 4:00 PM EST

GT Biopharma (GTBP) Current Deferred Tax Assets (2019 - 2020)

Updated

GT Biopharma's Current Deferred Tax Assets was $72,000 in Q3 2020, down 45.9% from $133,000 a year earlier and unchanged from the prior quarter.

Analysis

GT Biopharma (GTBP) Current Deferred Tax Assets (2019 - 2020) Analysis & Trends

At the end of FY2019, Current Deferred Tax Assets at GT Biopharma came in at $110,000.

  • Quarterly Current Deferred Tax Assets has moved between $72,000 (Q2 2020) and $153,000 (Q1 2019) over five years.
  • Compared with a year earlier, Current Deferred Tax Assets has declined for three straight quarters.
  • Per Business Quant data, GTBP's Current Deferred Tax Assets in the three quarters before Q3 2020 was $72,000 (Q2 2020), $95,000 (Q1 2020) and $110,000 (Q4 2019).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 GT Biopharma 6.65 Mn -16.58 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 72,000.00
Jun 30, 2020 72,000.00
Mar 31, 2020 95,000.00
Dec 31, 2019 110,000.00
Sep 30, 2019 133,000.00
Jun 30, 2019 147,000.00
Mar 31, 2019 153,000.00
API Access

GT Biopharma Current Deferred Tax Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-tax-assets&ticker=GTBP&period=max&api_key=YOUR_API_KEY